A new study published in the journal European Psychiatry has shed light on an unconventional approach to managing symptoms associated with Attention-Deficit Hyperactivity Disorder (ADHD). The findings suggest that small, repeated doses of substances like psilocybin and lysergic acid diethylamide (LSD) could potentially help reduce ADHD symptoms and enhance some aspects of emotion regulation. These findings could pave the way for new treatments that focus not only on the prima

Alzheimer’s disease (AD) stands as a formidable neurodegenerative ailment and a prominent contributor to dementia. The scarcity of available therapies for AD accentuates the exigency for innovative treatment modalities. Psilocybin, a psychoactive alkaloid intrinsic to hallucinogenic mushrooms, has garnered attention within the neuropsychiatric realm due to its established safety and efficacy in treating depression. Nonetheless, its potential as a therapeutic avenue for AD rem

People have used psychedelics to commune with the divine and create bonds among the living and the dead, the spiritual and the natural worlds for centuries and possibly millennia. Pre-Incan civilizations consumed the San Pedro cactus, which contains mescaline; Vedic and Zoroastrian traditions consumed soma, which some scholars believe may have been based on mushrooms containing psychoactive ingredients; Bantu diviners use psychedelic herbs called ubulawu during healing ceremo

In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance...

Have you ever wondered what goes on inside your brain during a psychedelic trip? The mysteries of psilocybin, the primary psychoactive...